title: Ivabradine in heart failure: hope or hype?
authors.affiliation: University of California, San Francisco School of Medicine, Fresno, CA 93703, USA. deed@fresno.ucsf.edu
authors.forename: Prakash C
authors.initials: PC
authors.lastname: Deedwania
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D001552:Benzazepines / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D054815:Cyclic Nucleotide-Gated Cation Channels / Q000037:antagonists & inhibitors*; D018450:Disease Progression; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D000077550:Ivabradine; D049990:Membrane Transport Modulators / Q000627:therapeutic use*
chemical_list: D000319:Adrenergic beta-Antagonists; D001552:Benzazepines; D002316:Cardiotonic Agents; D054815:Cyclic Nucleotide-Gated Cation Channels; D049990:Membrane Transport Modulators; D000077550:Ivabradine